Starting Wegovy: What to Expect With Your First Dose

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When you begin semaglutide therapy, your body enters a new metabolic phase designed to reduce hunger and support steady weight loss. The first injection activates GLP-1 receptors in your brain and gut within hours, though peak effects develop over several days. PlexusDx prescribes compounded semaglutide from licensed 503A pharmacies, allowing you to start at a dose tailored to your individual needs without requiring insurance or membership.

How Semaglutide Works During Your Initial Dose

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone controlling appetite and blood sugar. When you inject your first dose, the medication travels through your subcutaneous tissue and enters your bloodstream, reaching GLP-1 receptors throughout your nervous system. These receptors send signals to your hypothalamus—the brain region governing hunger—causing reduced appetite typically within the first 24 to 48 hours.

Beyond appetite suppression, semaglutide slows gastric emptying, meaning food moves more slowly from your stomach into your intestines. This prolonged fullness sensation persists for hours after eating, making it easier to consume smaller portions without feeling deprived. Many patients report that foods they previously craved no longer hold the same appeal, fundamentally shifting their relationship with eating.

Timeline: What to Expect in Your First Two Weeks

Hour one to six after injection: You may feel mild injection-site sensations like temporary redness or warmth, which typically resolve within minutes to hours. The medication begins diffusing into surrounding tissue, initiating its mechanism of action. Most patients experience no systemic symptoms during this phase.

Day one to three: Appetite suppression becomes noticeable for many people, though intensity varies based on starting dose and individual sensitivity. Some patients report mild nausea, especially if they eat larger meals or foods high in fat or sugar. This is your body's signal to eat smaller, lighter portions—a natural feedback loop that reinforces behavioral change.

Day four to fourteen: Gastrointestinal adjustment continues as your system adapts to slower digestion. Nausea typically peaks around day three to five, then gradually subsides as your body becomes accustomed to the medication. Energy levels often improve during this window as appetite stabilizes and eating patterns normalize.

Common First-Dose Side Effects and How to Manage Them

Nausea is the most frequently reported side effect during initial semaglutide therapy, occurring in approximately 25% to 40% of patients in the first weeks. Eating smaller, more frequent meals—especially those lower in fat and sugar—significantly reduces nausea severity. Ginger tea, peppermint, and adequate hydration also help settle your digestive system while it adapts to the medication's effects.

Constipation and occasional loose stools both occur because semaglutide slows intestinal movement and changes eating volume. Increasing water intake to 80 to 100 ounces daily, consuming fiber-rich vegetables, and gentle movement like walking promote digestive regularity. These gastrointestinal changes typically resolve within two to four weeks as your body equilibrates.

Injection-site reactions—mild redness, itching, or bruising—happen occasionally but rarely require treatment beyond basic wound care. Rotating injection sites between your abdomen, thigh, and upper arm reduces tissue irritation and improves medication absorption. If you experience severe swelling or signs of infection, contact your PlexusDx provider immediately.

Optimizing Your First Dose: Nutrition and Lifestyle

Dietary composition matters significantly during your first weeks on semaglutide. Focus on lean proteins, non-starchy vegetables, and healthy fats while minimizing processed foods, sugary beverages, and high-fat items that trigger nausea. Your natural appetite suppression makes this transition easier—you're not fighting hunger while changing eating habits, but rather working with your medication's effects.

Physical activity amplifies semaglutide's benefits without requiring intense exercise during your adjustment period. Gentle activities like 20 to 30 minutes of daily walking improve digestion, enhance mood, and accelerate metabolic adaptation. Many patients find they naturally gravitate toward movement as energy increases and joint stress from excess weight decreases.

Sleep and stress management support your metabolic response to semaglutide. GLP-1 receptors influence sleep architecture and stress hormone regulation, so prioritizing 7 to 9 hours nightly and practicing stress-reduction techniques amplifies medication efficacy. Consistency in your daily routine helps your body establish new physiological baseline patterns.

When to Expect Dose Adjustments and Weight Loss Results

PlexusDx personalizes your semaglutide protocol through the Precision Peptide Genetic Test, which analyzes your GLP1R rs6923761 variant and 48 other peptide-pathway markers. This genetic insight reveals your predicted receptor sensitivity, helping your provider calibrate your starting dose and escalation schedule for maximum effectiveness and minimal side effects. Your dose may need to increase over weeks or months as your system adapts, but your price remains flat at $149 per month across all dose levels.

Weight loss typically becomes visible after three to four weeks, with average losses of 1 to 2 pounds weekly during the first month. More significant results emerge at weeks eight to twelve as your medication reaches therapeutic steadiness and behavioral changes deepen. Clinical trials show that patients on semaglutide lose 10% to 15% of their body weight over six months, with continued losses through ongoing therapy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will I feel sick after my first semaglutide injection?

Some nausea occurs in 25-40% of patients within the first week, typically peaking around day three to five, then improving as your body adapts. Eating smaller meals lower in fat and sugar, staying hydrated, and taking ginger significantly reduce nausea severity. Contact your PlexusDx provider if nausea is severe or persists beyond two weeks.

How quickly does semaglutide suppress appetite?

Most patients notice reduced hunger within 24 to 48 hours of their first injection as GLP-1 receptors activate in the brain's appetite centers. Full effects develop over 3-7 days as medication concentration builds in your system. Individual timing varies based on starting dose, body composition, and genetic factors analyzed through the Precision Peptide Genetic Test.

Does PlexusDx charge more as my dose increases?

No. PlexusDx compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan flat, with no price increase regardless of dose level. Your dose may need to go up as your body adapts—your price won't. All medications come from licensed 503A compounding pharmacies and require no insurance or membership.

What's the difference between starting semaglutide and taking Wegovy?

Wegovy is an FDA-approved brand of semaglutide. PlexusDx offers compounded semaglutide from licensed 503A pharmacies at $189/month, which is typically more affordable than brand medications. Compounded versions contain identical active ingredients but allow personalized dosing without insurance approval delays. Both work through the same GLP-1 mechanism.

How does the Precision Peptide Genetic Test personalize my semaglutide therapy?

PlexusDx's Precision Peptide Genetic Test ($298) analyzes your GLP1R rs6923761 variant and 48 other peptide-pathway markers across 14 metabolic pathways. This reveals your predicted receptor sensitivity and response capacity, allowing your provider to optimize your starting dose and escalation schedule. Genetic insights dramatically improve outcomes by aligning treatment intensity with your biology.

Related Reading

• Victoza Starting Dose
• Trulicity Starting Dose
• Liraglutide Starting Dose
• Glp 1 Starting Dose

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.